AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 89 filers reported holding AVADEL PHARMACEUTICALS PLC in Q4 2022. The put-call ratio across all filers is 0.79 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,841,507 | +7.8% | 664,224 | +72.5% | 1.83% | +42.9% |
| Q2 2023 | $6,344,635 | +207.1% | 384,990 | -6.6% | 1.28% | +161.3% |
| Q3 2022 | $2,066,000 | +105.4% | 412,363 | 0.0% | 0.49% | +75.3% |
| Q2 2022 | $1,006,000 | -64.3% | 412,363 | 0.0% | 0.28% | -63.1% |
| Q1 2022 | $2,816,000 | -7.2% | 412,363 | +9.9% | 0.76% | +36.7% |
| Q4 2021 | $3,033,000 | -22.6% | 375,326 | -6.2% | 0.55% | -9.0% |
| Q3 2021 | $3,920,000 | – | 400,000 | – | 0.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 2,305,017 | $18,625,000 | 7.73% |
| COWEN AND COMPANY, LLC | 3,732,778 | $30,161,000 | 2.74% |
| GENDELL JEFFREY L | 2,446,299 | $19,766,000 | 1.60% |
| Asymmetry Capital Management, L.P. | 369,134 | $2,983,000 | 1.58% |
| Vivo Capital, LLC | 2,937,093 | $23,732,000 | 1.43% |
| Samsara BioCapital, LLC | 659,409 | $5,328,000 | 1.03% |
| Altium Capital Management LP | 440,589 | $3,560,000 | 0.98% |
| Knott David M Jr | 258,198 | $2,086,000 | 0.71% |
| RTW INVESTMENTS, LP | 5,741,939 | $46,395,000 | 0.68% |
| FRAZIER MANAGEMENT LLC | 951,814 | $7,691,000 | 0.59% |